glp-1 drugs for addiction IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target GLP-1 drugs protect against new
Description
The rise of the incretin therapies for obesity has attracted tremendous interest, both from drug developers and prospective patients (consumers)
Most are weekly injections, but oral formulations are becoming available
Why Calocurb Supplement Works Calocurb contains a bitter hops extract called Amarasate, which is a patented extract from New Zealand hops (Humulus lupulus)
Mol Metab 20:5162
Funding The author(s) declare that no financial support was received for the research and/or publication of this article
This compound is handled exclusively in controlled research settings for in vitro and pre-clinical studies, with no applications in human or veterinary medicine
